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Summary 
Class I major histocompatibility complex (MHC)-restricted CD8 + T  cells have been demon- 
strated to be effective mediators of both acquired and adoptive immunity to the intracellular 
bacterium Listeria monocytogenes. We have recently determined that L.  monocytogenes-infected 
H-2  a mice recognize a nonamer peptide, residues 91-99, of the secreted protein listeriolysin  O 
(LLO), in a H-2Kd-restricted  fashion. In this report we have generated CD8 + T cell lines with 
specificity for LLO 91-99 in the context of H-2K  a by in vitro stimulation with P815 (H-2  a) 
cells transfected with LLO. These CD8 + lines have been generated from immune donors after 
sublethal infection with L. monocytogenes, or after in vivo immunization with syngeneic spleen 
cells coated with synthetic LLO 91-99 peptide. LLO-specific CD8 + T cells derived from either 
protocol were capable of significant protection against L.  monocytogenes infection. The in vivo 
protection by these CD8 + T cell lines has been shown to be solely due to recognition of LLO 
91-99 in the context of H-2K  a. These studies demonstrate that CD8 § T  cell immunity to a 
single, naturally produced peptide epitope has the potential for significant protection in a bacterial 
infection. Thus, the allele-specific motif approach to epitope prediction has identified a naturally 
produced bacterial  epitope with biological relevance. 
T 
he resolution of an acute, sublethal infection with the 
facultative intracellular bacterium Listeria monocytogenes, 
and the subsequent long-lasting immunity to lethal infec- 
tion have been characterized as classic examples of cell-mediated 
immunity (1). A number of studies have dearly demonstrated 
that adoptive transfer ofT cells from immune donors, before 
or shortly after L. monocTtogenes infection of mice, can result 
in protection against bacterial replication in target organs such 
as spleen or liver (2-4). CD8 + T cells are the most effective 
T cell subset in these protection assays (5-10).  As first pro- 
posed by Mackaness (11), T cells are thought to protect against 
intracellular bacteria by a mechanism involving activation of 
the microbiddal activities of macrophages after antigen-driven 
lymphokine release. Evidence for this mechanism in L. mono- 
cxtogenes infection is based primarily on macrophage accumu- 
lation in target organs (12), the effectiveness of in vivo "ylFN 
treatment against L.  monocytogenes infections (13, 14), and 
the exacerbation of disease in mice treated with neutralizing 
mAb to ~/IFN (15). However, recent reports suggest that 3'IFN 
secretion by CD4-8-  cells may also play a role in resistance 
to L. monocxtogenes infection (16, 17). The role of cytokine 
release by CD8 + T cells in resolution of listeriosis has not 
been directly addressed, and a recent study questions the re- 
quirement for 3,IFN in resolution of infection (18). Thus, 
CD8 § T cell-mediated cytotoxicity against L. monocytogenes 
infected cells may function as a mechanism of protection in 
vivo, although in vivo lysis by CD8 + T  cells has not been 
directly demonstrated. 
In contrast to the body of evidence supporting a role for 
T cells in immunity to L. monocytogenes, several recent reports 
involving T cell subset depletion in vivo have questioned the 
role of CD8 + T  cells in resolution of acute listeriosis  and 
the relevance of the adoptive transfer assay within this con- 
text (16, 17, 19). In these studies, bacteria were cleared from 
the livers of infected mice with only slightly delayed kinetics 
in animals depleted of CD4 + and CD8 + T cells, suggesting 
that early 3,IFN production by CD4-8-  NK cells or q//6 
T cells may be critical in clearance of bacteria from this organ. 
However, similar studies by other investigators have shown 
that T cell-depleted mice (14) and mice with the SCID mu- 
tation (20) fail to completely resolve L. monocytogenes infec- 
tion, suggesting a role for T cells in this process. In the absence 
of further information, the simplest interpretation of these 
data suggests that many facets of the immune response may 
contribute to host defense against acute, sublethal L. mono- 
cytogenes infection, and that natural immunity clearly plays 
a  role in resolution of sublethal infection. Despite these 
conflicting results regarding the cells responsible for resolu- 
tion of acute listeriosis, it is clear that previously sensitized 
T  cells are capable of enhancing the protective capacity of 
natural immunity to L.  monocytogenes infection in vivo. 
To better understand protective CD8 + T  cell immunity 
1531  J. Exp.  Med. ￿9  The Rocl~fcller University Press ￿9 0022-1007/92/06/1531/08  $2.00 
Volume  175  June 1992  1531-1538 to intracellular  bacteria,  further  information  is needed re- 
garding the nature and number of bacterial proteins recog- 
nized through the endogenous antigen processing and pre- 
sentation pathway. L. monocytogenes  is a complex organism, 
producing perhaps 4,000 protein products with differentially 
regulated expression. Under these drcumstances, identification 
of the proteins contributing to class I MHC-restricted, im- 
munogenic peptide epitopes is a complex undertaking.  The 
use of gene transfection  technology allowed us to identify 
listeriolysin  O  (LLO) 1 as  a  target  molecule  for  H-2K  a- 
restricted  CD8 +  T  ceils  derived  from  L.  monocytogenes- 
infected mice (21). LLO is a sulflaydryl (SH)-activated cytotoxin 
secreted by virulent L.  monocytogenes  that permits entry of 
the organism into the cytoplasm of eukaryotic cells from the 
endocytic pathway (reviewed in 22). LLO secretion is neces- 
sary for L.  monocytogenes  to induce protective immunity in 
vivo (10), and to elidt 3'IFN production from specific CD8 + 
T  cells in vitro (23).  Heat-killed organisms and organisms 
mutant in LLO production are incapable of indudng  these 
responses (10, 23, 24). These observations have suggested a 
modal in which the requirement for LLO secretion for the 
induction of protective immunity is based on access of the 
bacterium to the cytoplasm of the infected cell (23). Cyto- 
plasmic localization is sufficient to introduce bacterial pro- 
teins into the class I MHC antigen processing pathway (25), 
resulting  in the potential  for CD8 + T  cell recognition. 
Recent advances in biochemical characterization  of class 
I MHC bound peptides have determined that individual class 
I alleles bind peptides of defined length that contain anchor 
residues of defined composition and spacing (26-28).  The 
motif identified for H-2K  a (27, 29) has allowed identifica- 
tion of a naturally produced nonamer epitope recognized by 
LLO-specific CD8 + T  cells  (21).  Since this epitope is pre- 
sented  by  H-2K  a  molecules  in  infected  mice,  it  has  the 
potential for relevance in immunity to L. monocytogenes.  In 
this study, we report  the derivation of CD8 + T  cell lines 
with spedficity for the identified LLO epitope and the in vivo 
biological activity of these T  cell lines. 
Materials  and Methods 
Mice.  Young female adult DBA/2J and Balb/cByJ mice were 
obtained from The Jackson Laboratories (Bar Harbor,  ME). 
Bacteria.  L. monocytogenes strain 43251 was grown in trypti- 
case soy broth (TSB, Becton Dickinson & Co., Cockeysviile, MD) 
to log phase, and aliquots were frozen and stored at - 700C. Freshly 
thawed bacterial stocks were allowed to return to log phase by in- 
cubation at 37eC for 3-4 h, and the bacteria were adjusted to the 
appropriate dilution for intravenous injection in 0.2 ml PBS. The 
LDs0 of this strain of L. monocytogenes for DBA/2J mice is <5  x 
103 CFU/animal. 
mAbs.  SF1-1.1 is a mouse IgG2a mAb specific for H-2K  a ob- 
tained from American Type Culture Collection (ATCC, Rockvilh, 
MD). Culture sup~  and protein G- (Pharmacia Fine Chem- 
icals, Hscataway, NJ) purified mAb were used in blocking experi- 
1 Abbra,  iations used in this paper. LLO, listeriolysin  O; SH, sulfhy&yl;  TSB, 
trypticase soy broth. 
merits. 34-4-20s is a mouse IgG2a mAh, and 34-4-21s a mouse IBM 
mAb, both of which are specific for H-2IY. These mAbs were ob- 
tained from ATCC, and both were used in the form of culture su- 
pernatant in blocking experiments. 3.168 is a rat anti-mouse mAb 
specific for CD8 (30) and was used to direct complement-mediated 
lysis of the CD8 ~ T cell lines. 
Acid Extraction of MHC Class I Bound Peptides from L.  mono- 
cytogenes-infected Spleens.  .Acid  extraction of dams I MHC bound 
peptides from 44-h L. monocyto&enes-~  spleens was performed 
as described previously, except that DBA/2 mice were infected with 
50 LDs0 (21). Briefly, spleens were harvested from infected animals 
and homogenized in 0.1% TFA. After 30-min incubation at 4~ 
insoluble material was removed by ultracentrifugation  for 35 rain 
at 180,000 g. Soluble material <10,000 molecular weight was re- 
covered after lyophilization and centrifugation  of the resuspended 
material through centricon  10 columns (Amicon, Beverly, MA), 
and was subjected to reverse phase FIPLC using the previously de- 
scribed conditions. Fractions were recovered, and prepared for anal- 
ysis in CTL assays as described (21). 
Priming  Mic~  CD8 +  T  cell line  479-2  was  derived  from 
DBA/2 mice that were infected intravenously with a sublethal dose 
of L. monocytogenes (5  x  102 CFU) 7 d before spleen harvest and 
in vitro stimulation.  CD8 + T cell line 603-1-2 was derived from 
DBA/2 mice that had been immunized 10 d earlier by intravenous 
injection of 2  x  107 irradiated (2,000 rad) syngeneic spleen ceils 
that had been incubated for I h at 370C with 1/~M LLO 91-99 
peptide in RPMI 1640 with 10% FCS and 50/~M 2-ME (RP10), 
and then  washed three times in RP10. 
Tumor Cells and Target Cells for CTL Assays.  The target cells 
used in this study were the dams II MHC-negative  P815 (DBA/2, 
H-2  a) mastocytoma and various transfectants of P815. Derivation 
of the LLO transfectant of P815, PHem3 has been described (21). 
PHem3.3 is a subclune of PHem3 derived by limit dilution,  while 
PBAc-1 is P815 transfected with the parental pFI~APr-l-neo vector 
(31) without insert. P13.4 is P815 transfected with the Escherichia 
coli/~-galactosidase  gene (32). 
In  Vitro Stimulation  of Effectors and Long-Term CD8 §  T  Cell 
Lines.  Primary in vitro stimulation of CD8 + T ceil lines was per- 
formed by incubating  35-40  x  106 immune spleen ceils with 3 
x  106 irradiated (20,000 lad) PHem3 or PHem3.3 for 7 d in 20 
ml RP10 in upright 25-cm  z flasks (#3013, Falcon, Becton Dick- 
inson  & Co.)  at 370C in 7%  CO2/air.  Subsequent  weekly re- 
stimuhtions  were carried out with 2.5  x  106 responder cells, 2-3 
x  106 irradiated PHem3.3 ceils, and 35  x  106 irradiated (2,000 
tad) syngeneic spleen ceils in 20 ml RP10 containing 5% superna- 
tant from Con A-stimulated rat spleen cells and 50 raM ~-methyl 
mannoside in upright  25-cra  2 flasks. The 0805B CD8 + T cell line 
was a gift of H.-G. Rammensee and is specific for E. coli t~-galac- 
tosidase in the context of H-2L  a (33). 0805B was maintained in 
analogous fashion to the LLO specific lines except that the stimu- 
lators were P13.4 ceils. 
CTL Assay.  Target ceils (106) in 300/~1 RP10 were hbeled 
with  100/~Ci  [SlCr]sodium chromate  for  1 h  at 37~  After 
washing,  104 target  ceils were incubated with serial dilutions  of 
effector ceils in 200/tl of R.Pl0 in round bottomed 96-well plates. 
The synthetic peptide representing LLO 91-99 (single letter code 
GYKDGNEYI) was added to the target ceils  just before their ad- 
dition to the wells. In vitro targeting  activity of HPLC fractions 
was assessed using 50 tzl of each resuspended fraction,  104 target 
cells, and the indicated number of effector CTL in 200/~1 RP10. 
After 3-4 h incubation at 370C, 100 td supematant  was collected 
and specific lysis was determined  as: pesv.ent specific lysis =  100 
x  [(release  by CTL -  spontaneous rdease)/(maximum release - 
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was <10% in all experiments. 
In Vivo Protection Assall.  CD8 § T cell lines were harvested at 
day eight or nine after stimulation and were washed twice in PBS 
before intravenous injection in 0.2 ml. Animals were infected 30 
min later by intravenous injection of 5  x  10  ~ L. monocytogenes (>1 
LDs0) in 0.2 ml PIGS. Organs were harvested 48 or 72 h after in- 
fiction and were homogenized (UItra-Turrax; Tekmar Co., Cin- 
cinnati,  OH) in sterile distilled water containing 0.2% NP-40. 
Splenic homogenates were performed in a 5 ml volume, while Liver 
homogenates were performed in 10 ml. Homogenates were in- 
cubated at room temperature for 30 rain and serial 10-fold dih- 
tions were made in 0.2% NP-40. ALiquots  of relevant dilutions 
were plated on TSB-agar, incubated 18-24 h, and the colonies 
enumerated. Colony counts from each series were corrected for 
dilution and averaged to yield CFU/organ. Detection Limits  were 
50 CFU/spleen and 100 CFU/Liver.  Student's t test was employed 
in the analysis of results. Each group consisted of three animals, 
and each experiment was performed at least twice with similar 
results. 
Results 
Generation  of LLO.specific  COS +  T  Cells from  Infected 
M/c~  The LID-expressing P815 transfectant, PHem3, is rec- 
ognized by CD8 + T  cells derived from L.  monocytogenes- 
infected H-2  a mice,  and a  nonarner peptide presented by 
H-2K  d has been identified as a target epitope (21). To assess 
the biological relevance of a CD8 + T  cell response to this 
protein,  we  sought  to  derive  CD8 +  T  ceil  lines  with 
specificity directed solely against LLO. DBA/2 (H-2  a) mice 
were sublethaUy infected with 5  x  102 L. monocytogenes via 
intravenous injection, and their spleen ceils were harvested 
7 d hter and stimulated in vitro with the MHC dass II-nega- 
tire PHem3 transfectant, or a subdone designated PHem3.3. 
After several rounds of in vitro stimulation, a CD8 + T cell 
line designated 479-2 was found to specifically lyse the LLO 
transfectant PHem3.3 and not the P815 cells transfected with 
the parental vector (Fig. 1). In addition, Fig. 1 demonstrates 
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Figure 1.  Generation of an LLO-specific CD8 + T  cell line from 
L. monocyto&enes-infected  mice. Line  479-2 was derived  from  DBA/2 mice 
7 d after  sublethal  infection  with L. monocTtogenes  by in vitro stimulation 
with the LEO-expressing  transfectaat  PHem3. The line was assayed  for 
CTL activity  against PHem3.3 (11), or the cells transfected  with the pa- 
rental vector, PBAc-1 in the presence (O) or absence (A) of 10 nM syn- 
thetic LEO 91-99. 
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Figure 2.  In vivo protection from L. monocytogenes  by LLO-speciflc 
CD8 + T cells. Spleens (A) and livers (B) were harvested  from  uninjected 
control  DBA/2 mice  (1"-1), or DBA/2  mice  that were  injected  intravenously 
with 15  x  10  ~ 479-2 CD8 + T cells (I) just before intravenous  infec- 
tion of both groups with 5  x  103 (>1 LDs0) L. monocytogenes. Bac- 
terial numbers per organ were determined  48 h after infection. Results 
are expressed as log10 CFU/organ (_+) SD of groups of three mice. 
that the 479-2 line is capable of lysing the control transfic- 
tant when incubated in the presence of the previously identified 
H-2Ka-restricted natural epitope, LLO 91-99. Thus, CD8 + 
T cell line 479-2 is specific for LLO in the context of H-2  a 
class I molecules and recognizes LLO 91-99 in the context 
of H-2K  d. 
In  Vivo  Protection  b  7  the  LLO-Specific  CD8 +  T  Cells. 
LLO is a secreted protein required for L. monocytogenes entry 
into the cytoplasm of the infected cell (reviewed in 22).  As 
such, it is likely to be one of the first bacterial proteins acces- 
sible to the class I MHC antigen processing pathway and thus, 
one of the first bacterial proteins to provide epitopes presented 
at the ceil surface during infection. In addition, dass I MHC 
presentation of LID epitopes should be independent of the 
need for bacterial destruction in the infected ceils. Under these 
drcumstances, a CD8 + T cell response to this protein might 
be effective at an early stage of L.  monocytogenes infection. 
We addressed this question by infusing line 479-2 into syn- 
geneic DBA/2 mice just before infection of the mice with 
>1 LDs0 of L.  monocytogenes. Using this type of protocol, 
previous experiments have shown that CD8 + T  cells from 
immunized mice (5-10)  or a MHC-urtrestricted CD8 + T 
cell done specific for L.  monocytogenes (34) are effective in 
protection from bacterial replication in spleen and liver. How- 
ever, these studies have not provided information regarding 
the nature of the bacterial protein(s) contributing the rele- 
vant epitopes in the protective response. Fig. 2 illustrates the 
results of such an experiment with the LID-specific line in 
which injection of 15  x  10  s 479-2  CD8 + T  cells just be- 
fore infection of DBA/2 mice with >1  LDs0 of L.  mono- 
cytogenes reduced the bacterial load by >3 logw in spleens, 
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Figure  3.  In vivo protection  by the 479-2 CD8 + T  cell line is dose 
dependent and specific (,4). Various numbers of 479-2 CD8 + T cells were 
injected  intravenously  followed by infection with 5  x  103 L.  monocyto- 
genes. Spleens were harvested and the numbers of bacteria per spleen de- 
termined  72 h  after infection.  Bacterial numbers  from animals infected 
with 5  x  103 L. raonocytogenes were determined  in spleens (B) and livers 
(C) after no injection  (F3), injection  of 10  x  106 of the E. coli/3-galac- 
tosidase-specific CD8 + T  cell line 0805B  ([~),  or injection  of 5  ￿  106 
479-2  CD8 + T  cells  (m), 
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Figure 4.  Line 479-2 recognizes  a single peak of activity from acid ex- 
tracts of L. monocytogenes.infected spleen, DBA/2 mice were injected in- 
travenously with 50 LDs0, and their spleens were harvested 44 h later for 
acid elution of peptides from class I molecules,  followed by reverse phase 
HPLC separation of low molecular  weight material, and analysis in the 
CTL  assay with  the 479-2  line (&),  or  without  CD8 +  T  ceils  (e). 
Effector to target ratio was 1:1. 
(Fig. 1). However, additional specificities for other epitopes 
have not been completely ruled out. Antibody blocking of 
line 479-2 lysis of the LLO transfectant indicates that lysis 
is inhibited only by anti-H-2K a antibodies  as was demon- 
strated with recognition of LID 91-99 (data not shown) (21). 
To determine whether other epitopes might be recognized 
by this line, peptides were acid extracted from DBA/2 spleens 
44 h  after infection with 50 LDs0 of L.  monocytogenes and 
separated  by  reverse  phase  HPLC  as  previously  described 
(21). Line 479-2 reactivity was confined to a single peak with 
maximal targeting activity in HPLC fraction 28, which has 
previously been identified as the fraction containing LLO 91-99 
(21) (Fig. 4). While these data do not rule out reactivity to 
other LLO peptides that may have identical elution charac- 
teristics,  they do strongly suggest, in conjunction with the 
ability of line 479-2 to very effldently lyse P815 cells incubated 
and by  >1.5 log10  in livers,  with respect  to control mice. 
The protective ability of the 479-2 CD8 + T  cells was dose 
dependent  (Fig.  3  A)  and specific  since  the  H-2a-derived 
CD8 + T cell line 0805B, which is specific for E. coli 3-galac- 
tosidase  in the  context  of H-2L d (33),  had no  protective 
effect  (Fig.  3,  B  and C).  This CD8 + T  cell line is main- 
tained in an analogous fashion to the 479-2 line by periodic 
stimulation with an irradiated  I)815 transfectant expressing 
B-galactosidase and irradiated syngeneic spleen cells. Line 479-2 
is >97% CD8 + by FACS  r  analysis, and anti-CD8 plus com- 
plement treatment completely removed the protective activity 
of the line (data not shown). These data demonstrate that a 
CD8 +  T  cell  response  to  the  secreted  LLO  molecule  is 
capable of inhibiting bacterial replication in mice infected with 
>1 LDs0 of L.  monocytogenes. 
CD8 +  T  Cell  Line  479-2  Is  Specific for  LID  91-99. 
CD8 + T cell line 479-2 dearly has specificity for LLO 91-99 
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Figure 5.  Dose response ofCD8 + T cell line 479-2 recognition of LLO 
91-99. The targets (1)815) and CD8 + T cells were incubated in the pres- 
ence of varying concentrations  of LLO 91-99 during a 4-h CTL assay. 
Effector to target ratio was 1:1. 
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Figure 6.  Generation of LLO 91-99-specific CD8 + T cell from peptide- 
immunized mice. Spleen cells from mice immunized with peptide-coated 
syngeneic  spleen cells were  stimulated  for several cycles in vitro with 
PHem3.3. The line was assayed for CTL activity against PHem3.3 (1), 
or the transfectant  control, PBAc-1 in the presence (O) or absence (A) 
of 10 nM synthetic  LLO 91-99. 
with LLO 91-99 peptide (Figs.  1 and 5),  that the in vivo 
biological activity of the line is due to recognition of the 
LLO 91-99 epitope in the context of H-2K  a. 
Generation of LLO 91-99-Specific  CD8 + T  Cells by Peptide 
Immunization.  To further determine whether the protective 
activity of LLO-specific CD8 + T cells in vivo is due to rec- 
ognition of LEO 91-99,  CD8 + T  cell lines were derived 
from peptide-immunized mice. Responder cells were spleen 
cells obtained from DBA/2 mice that had been immunized 
10 d earlier by intravenous injection of irradiated syngeneic 
spleen cells that had been incubated with 1 #M LEO 91-99 
at 37~  followed by extensive washing. Line 603-1-2 was 
derived from peptide-immunized  mice stimulated in vitro with 
the LEO transfectant, and specifically  lysed the PHem3.3 cells, 
as well as the transfectant control cells in the presence of syn- 
thetic LEO 91-99, but did not recognize the transfectant con- 
trol cells alone (Fig. 6). Line 603-1-2 was >97% CD8 + by 
FACS  |  analysis (data  not shown). 
In  Vivo Protection by CD8 §  T  Cells Derived from Peptide- 
immunized  Mice.  CD8 + T  cell line 603-1-2  should have 
specificity only for the LEO 91-99 epitope because of the 
in vivo peptide immunization protocol used. Naive spleen 
cells stimulated in vitro with PHem3.3 exhibited no response 
to the transfectant or the transfectant control cells (data not 
shown). It has been observed that CD8 + T cells derived by 
in vitro stimulation with peptides often will not recognize 
endogenously processed and presented antigen despite their 
ability to recognize peptide-coated targets (35, 36). Stimula- 
tion of the LEO 91-99 peptide-immune spleen cells in vitro 
with the LEO transfectant was carried out to expand CD8 + 
T cells with the ability to recognize endogenously presented 
antigens. 
The LLO  91-99-specific  CD8 +  T  cell  line  603-1-2  is 
capable of protecting DBA/2 mice from L. monocytogenes repli- 
cation, reducing  bacterial growth in both the spleens and livers 
of mice infected with >1 LDs0 (Fig.  7).  In addition, line 
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Figure 7.  In vivo protection by LID 91-99-specific CD8 § T cells. Bac- 
terial numbers  were determined  in spleens (A) and livers (B) 72 h after 
infection  with 5  ￿  103 L.  monocylogenes in uninjected  control animals 
(I-1), or in animals injected 30 min previously with 10  x  106 603-1-2 
CD8 § T  cells ([~), or 5  x  106 479-2 CD8 § T  cells (1). 
603-1-2 is capable of inhibiting L. monocytogenes replication 
in both spleens and livers of mice infected with >1 LDso 
when the CD8 § T cells are administered as late as 24 h after 
infection, reducing bacterial  titers by >1  log10 and  >1.5 
logt0,  respectively  (Fig.  8).  In  contrast,  multi-epitope- 
specific T cells obtained from immune donors 6 d after infec- 
tion have been found ineffective when injected 24 h postin- 
fection (19). These data confirm that in vivo protection against 
L.  monocytogenes can be mediated by CD8 § T  cells with 
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Figure 8.  LID 91-99-specific CD8 § T cells can affect L. monocytogenes 
replication when injected 24 h after infection. DBA/2 mice were infected 
intravenously with 5  ￿  103 L. raonocytogenes and one group (1) received 
15  ￿  106 603-1-2 CD8 + T cells 24 h after infection,  whereas the control 
group (Fq) received no CD8 + T cells. Bacterial numbers were determined 
in (.4)  spleens and (B) livers 72 h after infection. 
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tide immunization in vivo can elicit cells with protective ca- 
party after in vitro stimulation with endogenously processed 
and presented antigen. 
Discusaion 
CD8 + T cell-mediated immunity to L. monocytogenes has 
been hypothesized to result from antigen-specific release of 
T  cell-derived lymphokines, resulting in activation of mac- 
rophages (37, 38). However, the target protein(s) for this re- 
sponse have not been defined. In this report, we have demon- 
strated that a single, naturally produced epitope of nine amino 
acids in the LLO molecule can elicit CD8 + T cell responses 
capable of inhibiting L.  monocytogenes replication in H-2 d 
mice. In addition, we have shown that LLO 91-99-specific 
CD8 +  T  cells  can  reduce  bacterial  replication  in  target 
organs when injected 24 h after infection. This result is in 
contrast to the reported inability of T  cells  obtained from 
6-d infected animals to affect L. raonocytogenes  replication when 
injected 24 h after infection (19). The latter experiments were 
performed in H-2  bxa mice that have been shown to recog- 
nize LLO 91-99 (21). It is likely that the differences in these 
data result from differences in the number of LLO 91-99- 
specific CD8 + T cells injected. These data do not imply that 
the in vitro expanded CD8 + T  cells described in this study 
are more effldent in protection than multi-epitope-specific 
immune spleen cells, but do suggest that a substantial immune 
response to a single nonamer epitope can affect L. raonocy~genes 
replication even after 24 h  of infection. 
The protective CD8 + T cell responses were obtained after 
in vitro stimulation of immune spleen cells with a transfec- 
tant expressing the LLO molecule that is a secreted protein 
produced  early  in  the  intracellular  infection by  virulent 
L. monocytogenes (reviewed in 22). Thus, these experiments 
identify a dass of bacterial proteins, those secreted by the or- 
ganism during intracellular growth, as target proteins for pro- 
tective CD8 + T  cell-mediated immunity. The results are 
consistent  with  the  view  that  any  protein  reaching  the 
cytoplasm of an eukaryotic cell may be accessible to the class 
I MHC antigen processing pathway (25). In addition, a poten- 
tially important feature of epitopes derived from secreted bac- 
terial proteins is that they are likely to be presented early in 
the infection of a cell. While our experiments do not address 
the  mechanism  of protection  by  the  LLO  91-99-spedfic 
CD8 +  T  cells,  early  recognition  of the  infected  cell  by 
CD8 + T  cells could possibly expand the spectrum of effec- 
tive immunity to include lytic events, as well as the role for 
3,IFN/lymphokine production and macrophage activation. 
Under both of these scenarios, the immune CD8 + T  cells 
could function to effectively convert a lethal infection into 
a sublethal infection. This situation could then be dealt with 
via the components of the natural immune response to L. 
monocytogenes that are intact and contributing to the resolu- 
tion of infection in the protected animals. In contrast, dass 
I MHC-restricted presentation of epitopes derived from non- 
secreted proteins may require intracellular death and degra- 
dation of the organisms after their entry into the cytoplasm. 
These events may be relatively rare since 3,IFN-activated mac- 
rophages apparently prevent L. monocytogenes from exiting 
the endocytic vacuole (39), and the organism may be degraded 
without access to the cytoplasm in these cells. One testable 
hypothesis generated by these suggestions is that protective 
CD8 + T  cell immunity may be specific for epitopes found 
only in secreted proteins from L.  monocytogenes. 
The  ability  of single epitope-spedfic CD8 +  T  cell  re- 
sponses to protect against intracdlular pathogens other than 
viruses is somewhat controversial. In the L.  monocytogenes 
system, a MHC unrestricted CD8 + T  cell clone has been 
shown to have some protective effect in vivo, but the single- 
epitope specificity of the done was not rigorously demon- 
strated, and this clone required in vivo administration of fib2 
for effectiveness (34).  Thus, the nature of the recognition 
event in this protection experiment was undefined. In the 
mouse mode! of Plasraodiura berghei infection, some circum- 
sporozite-coat  protein-specific  CD8 +  T  cell  dones  ob- 
tained by in vitro stimulation with peptides were effective 
in vivo and some were not, despite having reactivity to the 
same 12 amino acid peptide (40), a finding that may be ex- 
plained by downmodulation of appropriate homing receptors 
on some dunes (41), or by isolation of peptide-specific dones 
that could not recognize endogenously presented antigen (35, 
36). In addition, repetitive immunization of mice with a trans- 
fectant expressing a single Plasmodium  faki~rura coat pro- 
tein yielded only partial protection, whereas immunization 
with  two  transfectants  expressing different  coat  proteins 
resulted in complete protection (42). The failure to generate 
a protective response after immunization can result either from 
the failure to dicit specific T  cells, or from the inability of 
the didted T  cells  to affect the outcome of the infection. 
Our results indicate that LLO 91-99-specific CD8 + T  cell 
lines generated from infected mice, or mice immunized with 
a synthetic peptide derived from the identified natural epi- 
tope are capable of mediating protection against L.  mono- 
cytogenes replication in infected mice. Analysis of the response 
of single epitope-specific T cell lines composed of oligodonal 
populations of responder cells may better reflect the in vivo 
response to antigen and its biological consequences than the 
response of individual T  cell clones. As we have shown, it 
is dearly feasible to generate single epitope-specific, high- 
affinity CD8 + T  cell lines using a combination of peptide 
immunization and in vitro stimulation with endogenously 
processed and presented antigen. This approach overcomes 
problems with peptide restimulations in vitro that can result 
in CD8 + T  cells capable of lysing peptide-coated cells, but 
that often fail to recognize endogenously presented antigen 
(35, 36), although exceptions exist at the donal level (43). 
Using this immunizationAtimulation approach we have de- 
termined that recognition of LLO 91-99 is relevant to pro- 
tection against L. monocytogenes, and that LLO 91-99 may 
be a candidate epitope for analysis of the conditions required 
for eflident peptide vaccination against intracellular pathogens. 
LLO 91-99 was identified using the allde-specific motif 
for H-2K a (21).  In this report,  we have extended this ap- 
proach to determine that the identified epitope has the potential 
to  elicit  CD8 +  T  cell  responses  capable  of  significantly 
1536  Protection against L. monooltogenes by Epitope-specific CD8 + T  Ceils affecting the outcome of infection with the intracdlular bac- 
terium L. raonocytogenes. Thus, this approach to epitope de- 
termination, which is based on the identification of allde- 
specific anchor residues  required for class I MHC binding 
(27, 28), has allowed the prediction of a T cell epitope with 
biological relevance in the infected animal. 
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